Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1101 | 1015 | 1162 | 1285 | 1343 | 1907 |
Fund Return | 10.12% | 1.53% | 16.25% | 8.72% | 6.08% | 6.67% |
Place in category | 194 | 371 | 138 | 79 | 131 | 51 |
% in Category | 44 | 77 | 37 | 18 | 33 | 19 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Fund | 5.06B | 10.08 | 8.25 | 6.32 | ||
Royal London FTSE 350 Tracker Z Fun | 5.06B | 10.06 | 8.07 | 6.28 | ||
Royal London European Growth Fund C | 2.33B | 5.25 | 5.75 | 8.44 | ||
Royal London US Tracker Z Fund Accu | 1.35B | 14.14 | 10.09 | 14.76 | ||
Royal London UK Equity Income Fund | 1.13B | 10.47 | 9.14 | 7.29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
GB00B2PLJH12 | 2.05B | 12.38 | 8.81 | 7.01 | ||
TB Evenlode Income B Income | 3.27B | 5.22 | 5.85 | 8.72 | ||
UK Equity Income Fund Retail Income | 137.7M | -2.33 | 7.02 | 4.93 | ||
UK Equity Income Fund Institutional | 90.61M | -2.24 | 7.61 | 5.51 | ||
UK Equity Income Fund Z Accumulatio | 672.45M | 10.40 | 7.25 | 7.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.80 | 31.29 | +0.27% | |
AstraZeneca | GB0009895292 | 4.66 | 10,676.0 | -3.32% | |
Unilever | GB00B10RZP78 | 4.12 | 56.46 | +0.21% | |
Relx | GB00B2B0DG97 | 4.02 | 3,625.43 | +0.23% | |
Imperial Brands | GB0004544929 | 3.47 | 2,372.00 | +0.55% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review